Advanced/Metastatic Breast Cancer Clinical Trials

12 clinical trials for Advanced/Metastatic Breast Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

Megestrol Acetate for Fatigue Management in T-DXd Treated Breast Cancer — RECRUITING · PHASE3
Dalpiciclib, Anti-HER2 Therapy, and Endocrine Therapy for Hormone-Receptor-Positive, HER2-Positive Metastatic Breast Cancer — RECRUITING · PHASE2
Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer — RECRUITING
Praegnant Breast Cancer: Early/Advanced/Metastatic — RECRUITING
A study in women with advanced breast cancer treated with standard therapy with or without MEDI-573 — COMPLETED · PHASE2
C4391024 - An Interventional, Open-Label, Randomized, Multicenter Phase 3 Study of PF-07220060 Plus Letrozole Compared to CDK4/6 Inhibitor Plus Letrozole in Participants Over 18 Years of Age With Hormone Receptor (HR)-Positive, HER2-Negative Advanced/Metastatic Breast Cancer who Have not Received any Prior Systemic Anticancer Treatment for Advanced/Metastatic Disease (FourLight-3) — TERMINATED · PHASE3
A Study to Investigate the Efficacy and Safety of Letrozole SIE Compared With Femara® (Both Combined With the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women With HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer — NOT_YET_RECRUITING · PHASE3
AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer — COMPLETED · PHASE1
Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer — COMPLETED · PHASE3
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer — COMPLETED · PHASE3
Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer — COMPLETED · PHASE3
Study Of Sunitinib With Capecitabine In Breast Cancer — COMPLETED · PHASE2

Refine this search